![Glenn L. Cooper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn L. Cooper
Chairman at
Lascaux Media LLC
Profile
Glenn L.
Cooper is currently the Chairman of Lascaux Media LLC.
He previously served as the Chairman & CEO of Indevus Pharmaceuticals, Inc. from 1996 to 2009, President & CEO of Progenitor, Inc. from 1992 to 1994, Executive Chairman of Fortress Biotech, Inc. from 2012 to 2013, Independent Director of Repligen Corp.
from 2009 to 2020, and Independent Director of Gentium Srl from 2009 to 2013.
He also served as the Director of Clinical Research at Lilly Research Center Ltd. from 1987 to 1990.
Additionally, he was the COO & Executive VP of Sphinx Pharmaceuticals Corp.
Dr. Cooper received his undergraduate degree from Harvard College and his doctorate from Tufts University School of Medicine.
Glenn L. Cooper active positions
| Companies | Position | Start |
|---|---|---|
Lascaux Media LLC | Chairman | - |
Former positions of Glenn L. Cooper
| Companies | Position | End |
|---|---|---|
| REPLIGEN CORPORATION | Director/Board Member | 2020-05-12 |
| GENTIUM S.P.A. (ADR) | Director/Board Member | 2013-03-26 |
| FORTRESS BIOTECH, INC. | Chief Executive Officer | 2011-03-31 |
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical compounds for urology, gynecology, and infectious diseases | Chief Executive Officer | 2008-12-31 |
Progenitor, Inc.
 Progenitor, Inc. BiotechnologyHealth Technology Develops pharmaceutical compounds for nervous system | President | 1994-05-31 |
Training of Glenn L. Cooper
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
51
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical compounds for urology, gynecology, and infectious diseases | Health Technology |
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Develops pharmaceutical compounds for nervous system | Health Technology |
Gentium Srl
 Gentium Srl Pharmaceuticals: MajorHealth Technology Manufactures and develops biopharmaceutical products for cancer treatments & vascular diseases | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
Sphinx Pharmaceuticals Corp
 Sphinx Pharmaceuticals Corp Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Lilly Research Center Ltd.
 Lilly Research Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Research Center Ltd. is a British company. | Health Technology |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lascaux Media LLC | |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Glenn L. Cooper
